|
Volumn 108, Issue 1, 2009, Pages 238-239
|
Etomidate infusion in the critical care setting for suppressing the acute phase of Cushing's syndrome
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CORTICOTROPIN;
DEXAMETHASONE;
DRUG METABOLITE;
ETOMIDATE;
HYDROCORTISONE;
KETOCONAZOLE;
ENZYME INHIBITOR;
STEROID 11 ALPHA HYDROXYLASE;
STEROID 11-ALPHA-HYDROXYLASE;
STEROID 17ALPHA MONOOXYGENASE;
STEROID MONOOXYGENASE;
UNCLASSIFIED DRUG;
ADOLESCENT;
ADRENALECTOMY;
ARTERIAL PRESSURE;
ARTHRALGIA;
ARTICLE;
BLOOD PRESSURE MONITORING;
BONE PAIN;
CASE REPORT;
CORTICOTROPIN BLOOD LEVEL;
CUSHING SYNDROME;
DISEASE COURSE;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG EXCRETION;
DRUG SELECTIVITY;
ELECTIVE SURGERY;
ELECTROCARDIOGRAM;
EXERCISE TEST;
FEMALE;
HOSPITAL DEPARTMENT;
HUMAN;
HYDROCORTISONE BLOOD LEVEL;
HYDROCORTISONE URINE LEVEL;
IMMOBILIZATION;
INTENSIVE CARE;
INTENSIVE CARE UNIT;
LIVER FUNCTION TEST;
MOON FACE;
MUSCLE ATROPHY;
PATIENT MONITORING;
PATIENT REFERRAL;
POSTOPERATIVE CARE;
PRIORITY JOURNAL;
PULSE OXIMETRY;
STRIA;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
UNIVERSITY HOSPITAL;
URINALYSIS;
ACUTE DISEASE;
BLOOD;
DRUG ANTAGONISM;
INTRAVENOUS DRUG ADMINISTRATION;
METABOLISM;
ORAL DRUG ADMINISTRATION;
URINE;
ACUTE DISEASE;
ADMINISTRATION, ORAL;
ADOLESCENT;
ADRENALECTOMY;
CRITICAL CARE;
CUSHING SYNDROME;
ENZYME INHIBITORS;
ETOMIDATE;
FEMALE;
HUMANS;
HYDROCORTISONE;
INFUSIONS, INTRAVENOUS;
KETOCONAZOLE;
STEROID 17-ALPHA-HYDROXYLASE;
STEROID HYDROXYLASES;
TREATMENT OUTCOME;
|
EID: 58749099297
PISSN: 00032999
EISSN: None
Source Type: Journal
DOI: 10.1213/ane.0b013e318187ed37 Document Type: Article |
Times cited : (16)
|
References (6)
|